Company: BDRX
Filing Date: 2025-09-26
Form Type: F-3
Source: 0001214659-25-014255
Chunk: 100

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-09-26
Form: F-3
Chunk 100
---
 in the applicable
prospectus supplement the security registrar, and any transfer agent in addition to the security registrar, that we initially designate
for any debt securities. We may at any time designate additional transfer agents or rescind the designation of any transfer agent or approve
a change in the office through which any transfer agent acts, except that we will be required to maintain a transfer agent in each place
of payment for the debt securities of each series.

If we elect to redeem the
debt securities of any series, we will not be required to:

| · | issue, register the transfer of, or exchange any debt securities of that series during a period beginning                              
 at the opening of business 15 days before the day of mailing of a notice of redemption of any debt securities that may be selected for 
 redemption and ending at the close of business on the day of the mailing; or                                                           |

| · | register the transfer of or exchange any debt securities so selected for redemption, in whole or in part, 
 except the unredeemed portion of any debt securities we are redeeming in part.                            |

Information Concerning the Debenture Trustee

The debenture trustee, other
than during the occurrence and continuance of an event of default under the applicable indenture, undertakes to perform only those duties
as are specifically set forth in the applicable indenture. Upon an event of default under an indenture, the debenture trustee under such
indenture must use the same degree of care as a prudent person would exercise or use in the conduct of his or her own affairs. Subject
to this provision, the debenture trustee is under no obligation to exercise any of the powers given it by the indentures at the request
of any holder of debt securities unless it is offered reasonable security and indemnity against the costs, expenses and liabilities that
it might incur.

Payment and Paying Agents

Unless we otherwise indicate
in the applicable prospectus supplement, we will make payment of the interest on any debt securities on any interest payment date to the
person in whose name the debt securities, or one or more predecessor securities, are registered at the close of business on the regular
record date for the interest.

We will pay the principal
of and any premium and interest due on the debt securities of a particular series at the office of the paying agents designated by us,
except that unless we otherwise indicate in the applicable prospectus supplement, will we make interest payments by check which we will
mail to the holder